NashwaWGabraMD

Internal Medicine • Burke, VA

Assistant Professor, Medicine, Georgetown University School of Medicine

Join to view full profile

Are you Dr. Gabra?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
5631 Burke Centre Pkwy
Suite A
Burke, VA 22015
Phone+1 703-250-5171

Fax+1 703-250-5170

Summary

Dr. Nashwa Gabra, MD is an internist in Burke, Virginia. She is currently licensed to practice medicine in Virginia. She is an Assistant Professor at Georgetown University School of Medicine.

Education & Training

Eastern Virginia Medical SchoolResidency, Internal Medicine, 2001 - 2002
District of Columbia General HospitalResidency, Internal Medicine, 1999 - 2001
Ain Shams University Faculty of MedicineClass of 1983

Certifications & Licensure

VA State Medical License 2001 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011

Clinical Trials

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
Terminated
Phase 2
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
Completed
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke Start of enrollment: 2019 Dec 17
Completed
Phase 4
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) Start of enrollment: 2020 Nov 04
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

139 citations
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial
Myron S. Cohen, Ajay Nirula, Mark J. Mulligan, Richard M. Novak, Mary A. Marovich
JAMA. 2021-07-06

Professional Memberships

American College of Physicians - ACP
Member